CYTK
Cytokinetics IncCompany with tickers: CYTK
CIK
1061983
CUSIP
23282W605
Shares Outstanding
135,770,593
Price History
Institutional Holders
Short Volume
Short Interest
Fails to Deliver
Financials
SEC Filings
Earnings Calls
Insider Trades
Congressional Trades
| Line Item | Value | Unit | Period End | Form | Filed |
|---|---|---|---|---|---|
| Revenue | — | ||||
| Revenue (ASC 606) | $19,355,000 | USD | 2026-03-31 | 10-Q | 2026-05-05 |
| Cost of Revenue | — | ||||
| Gross Profit | — | ||||
| Operating Expenses | $202,973,000 | USD | 2026-03-31 | 10-Q | 2026-05-05 |
| Research & Development | $95,525,000 | USD | 2026-03-31 | 10-Q | 2026-05-05 |
| Operating Income | $-183,618,000 | USD | 2026-03-31 | 10-Q | 2026-05-05 |
| Net Income | $-206,031,000 | USD | 2026-03-31 | 10-Q | 2026-05-05 |
| EPS (Basic) | $-1.67 | USD/shares | 2026-03-31 | 10-Q | 2026-05-05 |
| EPS (Diluted) | $-1.67 | USD/shares | 2026-03-31 | 10-Q | 2026-05-05 |